It seems we can’t find what you’re looking for. Perhaps searching can help.
Nothing found
Latest Articles
-
Tetra Bio-Pharma (OTC: TBPMF) (TSX: TBP) Current Price (8/3/21) $0.20 Upside Potential Target: $10.00 Next 18 months. Tetra Bio-Pharma (OTC: TBPMF), (TSX: TBP) has a robust clinical pipeline that targets markets valued at more [...]
Popular Articles
-
NOTE: NEXCF is no longer covered by Starwood Research. The subsequent stock price high after this report was published was $6.97. Analyst Notes NexTech AR Solutions (OTC: NEXCF) (CSE: NTAR) REVISED Upside Potential Target: US$20.00 [...]